Lupin's Pitolisant Tablets receives US FDA approval

Acurx receives FDA conditional acceptance for ibezapolstat brand name

Lttl announces new telehealth site

Phanes Therapeutics' Spevatamig receives US FDA Fast Track designation in advanced and metastatic biliary tract carcinoma

ArkBio's Ziresovir gains US FDA Phase II clinical trial approval

Rigel's VEPPANU (vepdegestrant) available for patients with ER+/HER2-, ESR1-mutated advanced or metastatic breast cancer

Innorna Nominated for 2026 Prix Galien USA Best Startup Award

Aurisco Pharmaceutical reports successful US FDA inspection

PTC to acquire BLA-stage ST-920 Fabry disease programme

Graviton BioScience's Investigational New Drug (IND) application for GV101 cleared for Friedreich's ataxia treatment

Galvanize Therapeutics' new Aliya EX System completes first commercial procedures

EIT Pharma's lonafarnib New Drug Application accepted for review by US FDA for chronic hepatitis D treatment

Lupin's Sodium Zirconium Cyclosilicate for Oral Suspension approved by US FDA

Labcorp receives FDA approval for melanoma companion diagnostic

Sobi partners with Innate Pharma to advance lacutamab in T-cell lymphoma